News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
231,174 Results
Type
Article (18674)
Company Profile (122)
Press Release (212378)
Section
Business (72447)
Career Advice (946)
Deals (12641)
Drug Delivery (36)
Drug Development (29092)
Employer Resources (70)
FDA (3847)
Job Trends (4726)
News (118035)
Policy (8583)
Tag
Academia (546)
Alliances (21457)
Alzheimer's disease (471)
Antibody-drug conjugate (ADC) (73)
Approvals (3833)
Artificial intelligence (94)
Bankruptcy (87)
Best Places to Work (3230)
Biotechnology (112)
Breast cancer (87)
Cancer (787)
Career advice (761)
CAR-T (80)
Cell therapy (239)
Clinical research (23341)
Collaboration (389)
Compensation (84)
COVID-19 (864)
C-suite (111)
Data (674)
Diabetes (63)
Diagnostics (1517)
Drug discovery (60)
Earnings (21420)
Employer resources (68)
Events (35982)
Executive appointments (335)
FDA (4161)
Funding (330)
Gene therapy (161)
GLP-1 (280)
Government (798)
Healthcare (3267)
Infectious disease (916)
Inflammatory bowel disease (72)
Interviews (137)
IPO (5264)
Job creations (1646)
Job search strategy (706)
Layoffs (162)
Legal (1992)
Lung cancer (104)
Manufacturing (139)
Medical device (1716)
Medtech (1718)
Mergers & acquisitions (7586)
Metabolic disorders (210)
Neuroscience (680)
NextGen: Class of 2025 (1574)
Non-profit (491)
Northern California (827)
Obesity (113)
Opinion (171)
Parkinson's disease (52)
Patents (65)
People (24771)
Phase I (8409)
Phase II (10747)
Phase III (6912)
Pipeline (361)
Postmarket research (515)
Preclinical (3334)
Press Release (62)
Radiopharmaceuticals (96)
Rare diseases (170)
Real estate (2800)
Regulatory (6384)
Research institute (572)
Resumes & cover letters (152)
Series A (77)
Southern California (767)
Startups (1997)
United States (7011)
Vaccines (222)
Weight loss (80)
Date
Today (34)
Last 7 days (243)
Last 30 days (1117)
Last 365 days (14329)
2025 (1906)
2024 (14557)
2023 (15625)
2022 (20796)
2021 (21192)
2020 (17477)
2019 (12314)
2018 (9651)
2017 (11545)
2016 (10441)
2015 (12294)
2014 (11984)
2013 (11227)
2012 (8141)
2011 (8531)
2010 (7797)
Location
Africa (375)
Asia (28589)
Australia (4327)
California (1925)
Canada (727)
China (228)
Connecticut (83)
Europe (38016)
Florida (199)
Illinois (135)
Indiana (96)
Japan (74)
Maryland (316)
Massachusetts (1531)
Michigan (72)
Minnesota (125)
New Jersey (582)
New York (521)
North Carolina (355)
Northern California (827)
Pennsylvania (406)
South America (477)
Southern California (767)
Texas (217)
Washington State (304)
231,174 Results for "sinovac biotech ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SINOVAC Issues Statement Regarding Privy Council Judgment
January 16, 2025
·
2 min read
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2023.
April 29, 2024
·
26 min read
Sinovac Amends Shareholder Rights Plan - February 21, 2024
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that its board of directors has amended its shareholder rights plan.
February 21, 2024
·
1 min read
Deals
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer - January 18, 2024
Sinovac Biotech Ltd. announced today that its Board of Directors (the “Board of Directors”) unanimously determined that the partial tender offer (the “Tender Offer”) by Alternative Liquidity Index LP (“Alternative Liquidity”).
January 18, 2024
·
9 min read
Press Releases
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
December 16, 2024
·
2 min read
Press Releases
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
December 18, 2024
·
4 min read
Executive appointments
Women Leaders Decline in Biotech’s Era of ‘Proven Leadership’
Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a
BioSpace
analysis. This is happening in an era of biotech where new company founders are searching for CEOs with a track record.
February 5, 2025
·
8 min read
·
Annalee Armstrong
Legal
Novo Seeks $830M in Fraud Case Against Singaporean Biotech Over Kidney Drug
Back in 2023, Novo Nordisk committed up to $1.3 billion for a hypertension and kidney disease drug from KBP Biosciences. Now, the pharma giant claims to have been misled by the biotech’s founder—and a judge seems to agree.
February 18, 2025
·
1 min read
·
Annalee Armstrong
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
Sinovac Biotech Ltd. announced that its Board of Directors unanimously determined that the partial tender offer by Alternative Liquidity Index LP to acquire up to 10,000,000 common shares of Sinovac for $0.03 per share in cash is NOT advisable and is NOT in the best interests of the Company or its shareholders.
September 5, 2023
·
9 min read
SINOVAC Reports Unaudited First Half of 2023 Financial Results
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced its unaudited financial results for the six months ended June 30, 2023.
August 15, 2023
·
22 min read
1 of 23,118
Next
